李悦 吴彤 陈述增 孙秋实 覃俐 许凌月. 克林霉素磷酸酯原料药杂质的分离制备和结构鉴定J. 药学学报, 2010,45(11): 1415-1420.
引用本文: 李悦 吴彤 陈述增 孙秋实 覃俐 许凌月. 克林霉素磷酸酯原料药杂质的分离制备和结构鉴定J. 药学学报, 2010,45(11): 1415-1420.
LI Yue, TUN Tong, CHEN Shu-Ceng, SUN Qiu-Shi, QIN Li, HU Ling-Ru. Isolation and identification of impurities from raw material of clindamycin phosphateJ. 药学学报, 2010,45(11): 1415-1420.
Citation: LI Yue, TUN Tong, CHEN Shu-Ceng, SUN Qiu-Shi, QIN Li, HU Ling-Ru. Isolation and identification of impurities from raw material of clindamycin phosphateJ. 药学学报, 2010,45(11): 1415-1420.

克林霉素磷酸酯原料药杂质的分离制备和结构鉴定

Isolation and identification of impurities from raw material of clindamycin phosphate

  • 摘要:

    通过制备液相色谱分离克林霉素磷酸酯 (clindamycin phosphate) 原料药中4个杂质, 并利用LC-MS方法、高分辨质谱、核磁共振等方法对杂质进行结构鉴定。4个杂质分别鉴定为克林霉素-B-磷酸酯 (1)2, 4-克林霉素二磷酸酯 (2)3', 6'-去氢克林霉素磷酸酯 (3) 和表克林霉素磷酸酯 (4)。杂质1为《英国药典》和《欧洲药典》在可能的杂质的收载项中收载的杂质, 杂质234均未收载, 为首次从克林霉素磷酸酯原料药中分得。

     

    Abstract:

    Four impurities were isolated from raw material of clindamycin phosphate (CP), and their   structures have been determined.  LC-MS was used to determine the molecular weights of the impurities in the raw material of CP.  Reversed-phase preparative HPLC was used to prepare them, and their chemical structures were identified by HR-MS and NMR.  The four unknown impurities were determined as clindamycin-B-phosphate (1), clindamycin-2, 4-diphosphate (2), 3', 6'-dehydro clindamycin phosphate (3), epi-clindamycin phosphate (4).  Impurity 1 has been included in BP and EP, while 2, 3 and 4 have not.  The impurities 2, 3, 4 are first separated from raw material of CP.

     

/

返回文章
返回